ZLY28 | MedChemExpress (MCE)
ZLY28 is the first-in-class intestinal restricted and orally active FXR and FABP1 dual modulator. ZLY28 also is a novel anti-NASH agent. ZLY28 can be used for the research of nonalcoholic steatohepatitis (NASH)[1].
| Trivial name | ZLY28 |
| Catalog Number | HY-149831 |
| Research Area | Metabolic Disease |
| Purity | ≥98.00% |
| SMILES | O=C(C1(C2=CC(C3=CC=C(OCC4=C(C5CC5)ON=C4C6=C(Cl)C=CC=C6Cl)C=C3)=CC=C2)CC1)O |
| PubChem Chemical Structure ID | 168355560 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/zly28.html |